In-stent restenosis of drug-eluting stents

被引:10
|
作者
Minha, Sa'ar [1 ,2 ]
Pichard, Augusto D. [1 ,2 ]
Waksman, Ron [1 ,2 ]
机构
[1] MedStar Washington Hosp Ctr, Intervent Cardiol, Washington, DC USA
[2] MedStar Washington Hosp Ctr, Washington, DC 20010 USA
关键词
bare metal stent; drug-eluting stent; in-stent restenosis;
D O I
10.2217/FCA.13.45
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Drug-eluting stents (DES) have emerged as an improved alternative to bare-metal stents by demonstrating reduced rates of restenosis and target lesion revascularization. This emergence has led to the unrestricted use of DES for various indications and lesions, and subsequently revealed DES in-stent restenosis as a novel interventional therapeutic dilemma. Recent insights regarding the pathophysiological processes and therapeutic alternatives have added to the accumulated knowledge regarding the appropriate approach to this phenomenon. This review aims to detail the mechanism and clinical presentation of, and therapeutic strategies for, the treatment of DES in in-stent restenosis.
引用
收藏
页码:721 / 731
页数:11
相关论文
共 50 条
  • [31] Drug-eluting stents: new presumed effects over in-stent restenosis prevention
    Macovei, Liviu
    Magopet, Robert
    Campo, Gianluca
    MINERVA CARDIOLOGY AND ANGIOLOGY, 2021, 69 (02) : 141 - 143
  • [32] Repeat In-Stent restenosis of drug-eluting stents in a bifurcation treated successfully with kissing drug eluting balloons
    Abergel, Eitan
    Beyar, Rafael
    Roguin, Ariel
    CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2013, 14 (02) : 106 - 108
  • [33] Drug eluting stents and modern stent technologies for in-stent restenosis
    Werner, Martin
    JOURNAL OF CARDIOVASCULAR SURGERY, 2017, 58 (04): : 497 - 500
  • [34] Clinical Presentation and Outcomes of In-stent Restenosis in Second-Generation Drug-Eluting Stents Compared to First Generation Drug-Eluting Stents
    Buchanan, Kyle
    Rogers, Toby
    Xu, Linzhi
    Iantorno, Micaela
    Gajanana, Deepak
    Ben-Dor, Itsik
    Suddath, William
    Satler, Lowell
    Waksman, Ron
    JACC-CARDIOVASCULAR INTERVENTIONS, 2018, 11 (04) : S18 - S18
  • [35] One Case of Using Drug-eluting Balloon to Treat Drug-eluting Stent In-stent Restenosis
    Qiang, Lyu
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (16) : S227 - S228
  • [36] The efficacy and safety of drug-eluting balloons for the treatment of in-stent restenosis as compared with drug-eluting stents and with conventional balloon angioplasty
    Oh, Pyung Chun
    Suh, Soon Yong
    Kang, Woong Chol
    Lee, Kyounghoon
    Han, Seung Hwan
    Ahn, Taehoon
    Shin, Eak Kyun
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2016, 31 (03): : 501 - 506
  • [37] Drug-eluting stent for recurrent mesenteric artery in-stent restenosis
    Cardaioli, Paolo
    Rigatelli, Gianluca
    Zattoni, Luca
    Giordan, Massimo
    JOURNAL OF ENDOVASCULAR THERAPY, 2007, 14 (05) : 748 - 751
  • [38] Drug-eluting stents to prevent stent thrombosis and restenosis
    Im, Eui
    Hong, Myeong-Ki
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2016, 14 (01) : 87 - 104
  • [39] Myths and Truths in the Management of Drug-Eluting Stent In-Stent Restenosis
    Waksman, Ron
    Chitturi, Kalyan R.
    JACC-CARDIOVASCULAR INTERVENTIONS, 2024, 17 (01) : 14 - 16
  • [40] Drug-Eluting Stent as an Option for Intractable In-Stent Coronary Restenosis
    Hachinohe, Daisuke
    Jeong, Myung Ho
    Kim, Min Chol
    Cho, Kyung Hoon
    Ahmed, Khurshid
    Hwang, Seung Hwan
    Lee, Min Goo
    Sim, Doo Sun
    Park, Keun-Ho
    Kim, Ju Han
    Hong, Young Joon
    Ahn, Youngkeun
    Kang, Jung Chaee
    KOREAN CIRCULATION JOURNAL, 2011, 41 (11) : 677 - 680